Scarica l'app Stockscreener
4.25
5.99%
0.24
Dopo l'orario di chiusura:
4.03
-0.22
-5.18%
C 4 Therapeutics Inc Azioni (CCCC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
6.81%
3.039
|
3.261 | 11.07 | 2.664 | 3.759 |
Operating Expenses
|
13.35%
35.26
|
40.69 | 38.88 | 40.23 | 39.99 |
| Benefits Costs and Expenses |
16.79%
31.40
|
37.74 | 37.11 | - | 38.54 |
| Costs And Expenses |
16.79%
31.40
|
37.74 | 37.11 | 40.23 | 38.54 |
| Operating Income/Loss |
13.92%
-32.22
|
-37.43 | -27.81 | -37.57 | -36.23 |
| Nonoperating Income/Loss |
30.78%
3.858
|
2.95 | 1.774 | 1.646 | 1.448 |
| Income/Loss From Continuing Operations Before Tax |
17.74%
-28.36
|
-34.48 | -26.03 | -35.92 | -34.78 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.277 | 1.003 | - | - |
| Income/Loss From Continuing Operations After Tax |
18.40%
-28.36
|
-34.75 | -27.04 | -35.92 | -34.78 |
|
Net Income/Loss
|
18.40%
-28.36
|
-34.75 | -27.04 | -35.92 | -34.78 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
12,640%
68.43
|
0.5372 | 49.21 | 49.06 | 49.03 |
| Diluted Average Shares |
12,640%
68.43
|
0.5372 | 49.21 | 49.06 | 49.03 |
| Basic Earnings Per Share |
39.71%
-0.41
|
-0.68 | -0.55 | -0.73 | -0.71 |
| Diluted Earnings Per Share |
39.71%
-0.41
|
-0.68 | -0.55 | -0.73 | -0.71 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.89%
2.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):